Last reviewed · How we verify
Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older
Approved treatments
- Ppsv23 · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older treatment landscape brief
- Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older treatment updates RSS
Frequently asked questions about Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older
What drugs treat Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older?
Tracked treatments include Ppsv23.
What is the treatment for Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older?
Standard treatment for Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older includes Ppsv23. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older patent cliff · Prevention of invasive disease caused by Streptococcus pneumoniae in adults 50 years of age or older CI report
- Treatment: Ppsv23 · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing